BioReperia is located at Linköpings University. Our researchers have more than 10 years experience developing and using zebrafish models for medical research including toxicology and tumor biology. Our models are today widely used in both academic and industrial research and drug development projects around the globe.
Anna Fahlgren, University lecturer in experimental orthopedics, is an expert in biomechanical aspects of cellular metabolism. Her research has been focused on the role of mechanical strain and fluid shear stress on bone resorption in particular in association with implants. Dr. Fahlgren leads BioReperia’s programs on developing methods for including fluid pressure and advanced co-culture and 3D scaffolds in cell culture experiments leading to a closer approximation to in vivo biology and more accurate determination of drug effects.
Lasse Jensen is a Junior University Lecturer in vascular biology. His research interests primarily deal with the role of hypoxia on pathological angiogenesis and vascular destabilization in the eye or in tumors. Dr. Jensen has published highly on zebrafish models and are credited with developing several assay systems based on zebrafish embryos used widely for research on toxicology or tumor biology today, including the zebrafish tumor xenograft assay. Dr. Jensen leads BioReperia’s programs on advancing the use of zebrafish embryos for analysis of drug effects in vivo.